Ipsen
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Launch date
Employees
Market cap
€8.7b
Enterprise valuation
€8.5b (Public information from Sep 2024)
Share price
€109 IPN.PA
Boulogne-Billancourt Île-de-France (HQ)
No columns specified